Both in Pharmaceuticals
Inovio Pharmaceuticals vs AN2 Therapeutics
Over the past year INO returned −33.3% and ANTX returned +272.8%; their daily moves had a correlation of 0.02.
INO −33.3% ANTX +272.8%Growth of $1, one year, split-adjusted
| Metric | INO | ANTX |
|---|---|---|
| Price | $1.62 | $4.25 |
| Market cap | $167.5M | $160.4M |
| Today | −2.41% | +1.67% |
| 1 month | +43.4% | −16.2% |
| 6 months | +30.6% | −8.6% |
| Year to date | −6.9% | +272.8% |
| 1 year | −35.2% | +269.6% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $36.7M | $78.4M |
| Dividend yield | — | — |
| Volatility (60d) | 261.2% | 75.2% |
| Short % of float | 26.3% | 10.0% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).